Myconostica said this week that its MycAssay Aspergillus and MycAssay Pneumocystis have received CE marking on the Roche LightCycler 2.0 and Stratagene Mx3000 series platforms.
The CE marking on these two platforms is in addition to existing CE marks for the tests on the Cepheid SmartCycler and Life Technologies Applied Biosystems 7500, Manchester, UK-based Myconostica said.
MycAssay Aspergillus detects Aspergillus spp. DNA in lower respiratory tract samples. Meantime, the MycAssay Pneumocystis detects Pneumocystis jirovecii DNA in lower respiratory tract samples. Both assays are designed to be used by qualified laboratory professionals and to aid physicians in diagnosing patients.
When used in conjunction with Myconostica's fungal DNA extraction system, MycXtra, a result can be obtained within three hours of sample receipt, Myconostica said.